Azactam and Atarax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azactam (aztreonam) and Atarax (hydroxyzine hydrochloride). Common drug interactions include bile duct stone among females and haemoptysis among males.

The phase IV clinical study analyzes what interactions people have when they take Azactam and Atarax. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Azactam?

Azactam has active ingredients of aztreonam. eHealthMe is studying from 1,044 Azactam users. Check the latest studies of Azactam.

What is Atarax?

Atarax has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 23,553 Atarax users. Check the latest studies of Atarax.



On Jul, 14, 2026

30 people who take Azactam and Atarax together, and have interactions are studied.

Azactam and Atarax drug interactions.

What are the common drug interactions of Azactam and Atarax, by gender? *:

female:

  1. Bile duct stone
  2. Blood pressure decreased
  3. Chest discomfort
  4. Cholangitis acute (rapid infection of bile duct)
  5. Cholecystitis (infection of gallbladder)
  6. Pancreatitis (inflammation of pancreas)
  7. Paraplegia (paralysis of the legs and lower body)
  8. Pyelonephritis (inflammation of kidney caused by bacteria)
  9. Thermal burn (burn by heat)
  10. Urinary tract infection

male:

  1. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  2. Asthenia (weakness)
  3. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  4. Night sweats (sweating in night)
  5. Productive cough
  6. Pseudomonas test positive
  7. Pyrexia (fever)
  8. Secretion discharge
  9. Sputum discoloured
  10. Sputum increased

What are the common drug interactions of Azactam and Atarax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Weight increased
  2. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  3. Asthenia (weakness)
  4. Chest discomfort
  5. Chest pain
  6. Cough
  7. Decreased appetite
  8. Diarrhoea
  9. Dyspnoea (difficult or laboured respiration)
  10. Headache (pain in head)

40-49:

n/a

50-59:

  1. Bacterial sepsis
  2. Bone marrow failure
  3. Coagulopathy (blood's ability to clot is impaired)
  4. Diabetes mellitus inadequate control
  5. Hepatocellular injury (liver injury)
  6. Anaemia (lack of blood)
  7. Leukopenia (less number of white blood cells in blood)
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Engraft failure

60+:

  1. Bile duct stone
  2. Blood pressure decreased
  3. Iron deficiency anaemia
  4. Cystitis (inflammation of the wall of the bladder)
  5. Large intestine perforation (hole in large intestine)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  8. Chest discomfort
  9. Cholangitis acute (rapid infection of bile duct)
  10. Cholecystitis (infection of gallbladder)

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 9 people, 30.00%
  2. Pancreatitis (inflammation of pancreas): 8 people, 26.67%
  3. Paraplegia (paralysis of the legs and lower body): 8 people, 26.67%
  4. Urinary Tract Infection: 8 people, 26.67%
  5. High Blood Pressure: 8 people, 26.67%
  6. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 8 people, 26.67%
  7. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 8 people, 26.67%
  8. Hypotension (abnormally low blood pressure): 8 people, 26.67%
  9. Cholecystitis (infection of gallbladder): 8 people, 26.67%
  10. Cholangitis Acute (rapid infection of bile duct): 8 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take Azactam and Atarax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Azactam and Atarax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azactam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atarax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azactam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atarax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aztreonam and hydroxyzine hydrochloride (the active ingredients of Azactam and Atarax, respectively), and Azactam and Atarax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: